NCT02053909View on ClinicalTrials.gov

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2021

Conditions
Saphenous Vein Graft Disease
Interventions
DRUG

Aspirin

DRUG

Ticagrelor

Trial Locations (2)

33486

Boca Raton Regional Hospital, Boca Raton

Unknown

University of Ottawa Heart Institute, Ottawa

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Ottawa Heart Institute Research Corporation

OTHER

lead

Boca Raton Regional Hospital

OTHER